IDEAYA Biosciences (IDYA) Non-Current Assets (2018 - 2026)

IDEAYA Biosciences has disclosed Non-Current Assets across 9 years of filings, most recently posting $334.2 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $334.2 million, down 14.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 8.58% YoY), and the FY2025 annual result was $442.6 million, up 1.89% from the prior year.
• Non-Current Assets came in at $334.2 million for Q1 2026 at IDEAYA Biosciences, down from $442.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $442.6 million in Q4 2025 to a low of $17.5 million in Q3 2022.
• The 5-year median for Non-Current Assets is $252.2 million (2024), against an average of $210.6 million.
• Across the five-year window, Non-Current Assets plunged 86.61% in 2022 and jumped 1113.07% in 2024, its largest moves.
• IDEAYA Biosciences' Non-Current Assets stood at $17.5 million in 2022, then jumped by 566.19% to $116.7 million in 2023, then soared by 272.27% to $434.4 million in 2024, then gained by 1.89% to $442.6 million in 2025, then slipped by 24.48% to $334.2 million in 2026.
• The last three Non-Current Assets figures came in at $334.2 million (Q1 2026), $442.6 million (Q4 2025), and $382.5 million (Q3 2025), per Business Quant data.